Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib + Liposomal Doxorubicin + Dexamethasone in Plasma Cell Leukemia
NCT01328236Phase 2Unknown
- Start
- Sep 2010
- Primary completion
- Sep 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in plasma cell leukemia (PCL). Status: unknown.
02
Drugs
bortezomib
03
Conditions
plasma cell leukemia (PCL)
Beyond the preview
Go deeper on NCT01328236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01328236.